Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Higuchi

Showing results (221-230 of 286) with videos related to

Pageof 29
Sort By:
Cancer Chemotherapy and Pharmacology|April 1, 2019
The combination of olaratumab with gemcitabine and docetaxel arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma in a patient-derived orthotopic xenograft mouse modelTakashi Higuchi, Kentaro Miyake, Norihiko Sugisawa, et al.
Anticancer Research|August 28, 2024
Overcoming High Trabectedin Resistance of Soft-tissue Sarcoma With Recombinant Methioninase: A Potential Solution of a Recalcitrant Clinical ProblemSei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Cancer Medicine|April 20, 2023
Novel predictors of immune checkpoint inhibitor response and prognosis in advanced non-small-cell lung cancer with bone metastasisYohei Asano, Norio Yamamoto, Satoru Demura, et al.
Frontiers in Oncology|April 18, 2022
The Therapeutic Effect and Clinical Outcome of Immune Checkpoint Inhibitors on Bone Metastasis in Advanced Non-Small-Cell Lung CancerYohei Asano, Norio Yamamoto, Satoru Demura, et al.
Anticancer Research|July 26, 2024
Recombinant Methioninase Is Selectively Synergistic With Doxorubicin Against Wild-type Fibrosarcoma Cells Compared to Normal Cells and Overcomes Highly-Doxorubicin-resistant FibrosarcomaSei Morinaga, Qinghong Han, Kohei Mizuta, et al.
International Orthopaedics|March 27, 2017
Intercalary frozen autograft for reconstruction of malignant bone and soft tissue tumoursKarem M Zekry, Norio Yamamoto, Katsuhiro Hayashi, et al.
Anticancer Research|August 28, 2024
Recombinant Methioninase Increases Eribulin Efficacy 16-fold in Highly Eribulin-resistant HT1080 Fibrosarcoma Cells, Demonstrating Potential to Overcome the Clinical Challenge of Drug-resistant Soft-tissue SarcomaSei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Life (Basel, Switzerland)|January 21, 2023
Development of a Nanotechnology Matrix-Based Citronella Oil Insect Repellent to Obtain a Prolonged Effect and Evaluation of the Safety and EfficacyCelio Takashi Higuchi, Caroline Cianga Sales, Newton Andréo-Filho, et al.
Biological & Pharmaceutical Bulletin|April 2, 2023
Machine Learning-Based Prediction of Digoxin Toxicity in Heart Failure: A Multicenter Retrospective StudyYuki Asai, Takumi Tashiro, Yoshihiro Kondo, et al.
In Vivo (Athens, Greece)|October 30, 2024
Accurate and Safe Tumor Targeting of Orally-administered <i>Salmonella typhimurium</i> A1-R Leads to Regression of an Aggressive Fibrosarcoma in Nude MiceSei Morinaga, Ming Zhao, Kohei Mizuta, et al.
Pageof 29

Showing results (221-230 of 286) with videos related to

Sort By:
Pageof 29
Cancer Chemotherapy and Pharmacology|April 1, 2019
The combination of olaratumab with gemcitabine and docetaxel arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma in a patient-derived orthotopic xenograft mouse modelTakashi Higuchi, Kentaro Miyake, Norihiko Sugisawa, et al.
Anticancer Research|August 28, 2024
Overcoming High Trabectedin Resistance of Soft-tissue Sarcoma With Recombinant Methioninase: A Potential Solution of a Recalcitrant Clinical ProblemSei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Cancer Medicine|April 20, 2023
Novel predictors of immune checkpoint inhibitor response and prognosis in advanced non-small-cell lung cancer with bone metastasisYohei Asano, Norio Yamamoto, Satoru Demura, et al.
Frontiers in Oncology|April 18, 2022
The Therapeutic Effect and Clinical Outcome of Immune Checkpoint Inhibitors on Bone Metastasis in Advanced Non-Small-Cell Lung CancerYohei Asano, Norio Yamamoto, Satoru Demura, et al.
Anticancer Research|July 26, 2024
Recombinant Methioninase Is Selectively Synergistic With Doxorubicin Against Wild-type Fibrosarcoma Cells Compared to Normal Cells and Overcomes Highly-Doxorubicin-resistant FibrosarcomaSei Morinaga, Qinghong Han, Kohei Mizuta, et al.
International Orthopaedics|March 27, 2017
Intercalary frozen autograft for reconstruction of malignant bone and soft tissue tumoursKarem M Zekry, Norio Yamamoto, Katsuhiro Hayashi, et al.
Anticancer Research|August 28, 2024
Recombinant Methioninase Increases Eribulin Efficacy 16-fold in Highly Eribulin-resistant HT1080 Fibrosarcoma Cells, Demonstrating Potential to Overcome the Clinical Challenge of Drug-resistant Soft-tissue SarcomaSei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Life (Basel, Switzerland)|January 21, 2023
Development of a Nanotechnology Matrix-Based Citronella Oil Insect Repellent to Obtain a Prolonged Effect and Evaluation of the Safety and EfficacyCelio Takashi Higuchi, Caroline Cianga Sales, Newton Andréo-Filho, et al.
Biological & Pharmaceutical Bulletin|April 2, 2023
Machine Learning-Based Prediction of Digoxin Toxicity in Heart Failure: A Multicenter Retrospective StudyYuki Asai, Takumi Tashiro, Yoshihiro Kondo, et al.
In Vivo (Athens, Greece)|October 30, 2024
Accurate and Safe Tumor Targeting of Orally-administered <i>Salmonella typhimurium</i> A1-R Leads to Regression of an Aggressive Fibrosarcoma in Nude MiceSei Morinaga, Ming Zhao, Kohei Mizuta, et al.
Pageof 29